Axumin Injection, Solution
Product Images NDC 69932-001

3 FDA label images from Blue Earth Diagnostics · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Axumin (NDC 69932-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blue Earth Diagnostics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Axu00 0004 01)

Structural Formula (Axu00 0004 01)
Chemical structure of Fluciclovine F-18, the active ingredient in Axumin injection solution, shown as a molecular diagram with labeled atoms including fluorine-18.*
FDA Label Image

Blue Earth Diagnostics Logo (Axu00 0004 02)

FDA Label Image

Principal Display Panel (30 mL Multiple-Dose Vial Label)

Principal Display Panel (30 mL Multiple-Dose Vial Label)
Axumin (fluciclovine F-18) injection label for a multiple-dose vial. The solution strength is 335 MBq/mL to 8,200 MBq/mL (9 mCi/mL to 221 mCi/mL) for intravenous diagnostic use only. The label includes storage instructions at controlled room temperature (20°C to 25°C), radioactive caution, and manufacturer details for Blue Earth Diagnostics. It also notes expiration 10 hours after synthesis and contains spaces for batch, date, activity, concentration, volume, and expiry times.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.